EcoDrugPlus

Protein Kinase C Delta

Ensembl ID : ENSLBEG00000026270
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSLBEG00000018188
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSLBEG00000026816
Gene Symbol: PRKCE
3 Cross references
87 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSLBEG00000023334
Gene Symbol: PRKCH
3 Cross references
224 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSLBEG00000013658
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSLBEG00000016647
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSLBEG00000022846
Gene Symbol: PRKCQ
1 Cross references
204 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSLBEG00000004909
Gene Symbol: PRKD1
3 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSLBEG00000012706
Gene Symbol: PRKD3
3 Cross references
209 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSLBEG00000023509
Gene Symbol: PRKD3
2 Cross references
201 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSLBEG00000028626
Gene Symbol: PRKDC
3 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSLBEG00000028337
Gene Symbol: PPP3CA
4 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).